{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-060802","form_type":"8-K/A","ticker":"GRTX","cik":"0001563577","company_name":"Galera Therapeutics, Inc.","filed_at":"2025-03-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.001844+00:00","generated_at":"2026-05-24T06:32:52.914265+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"medium","headline":"Galera completes acquisition of Nova Pharmaceuticals, files 8-K/A with SEC waiver for financial statements","bullets":["Acquisition of Nova Pharmaceuticals closed on Dec 30, 2024, via merger agreement.","SEC granted waiver from Rule 3-05 and Article 11, allowing omission of audited FY2023 and unaudited interim financials for 9 months ended Sep 30, 2023/2024.","Pro forma financial information also omitted under the waiver.","No deal value or terms disclosed in this filing; full financial impact not provided to investors."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-060802","json":"https://secwatch.observer/filing/0001193125-25-060802.json","markdown":"https://secwatch.observer/filing/0001193125-25-060802.md","text":"https://secwatch.observer/filing/0001193125-25-060802.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1563577/000119312525060802/0001193125-25-060802-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1563577/000119312525060802/d928346d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T06:32:52.914265+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}